Finland starts the implementation of European biomedical research infrastructures (BMS ESFRIs) by investing in a national effort called Biomedinfra - a joint effort linking to the EU level initiatives in developing biobanking (BBMRI), bioinformatics (ELIXIR), and translational research (EATRIS) infrastructures.
This investment follows the 3-year pan-European planning phase, and a Finnish 2 M pilot project for Biomedinfra completed in 2010.
The approach that Finland has selected is based on the realisation that biobanking, bioinformatics and translational biomedical research infrastructures support one another and all of them build on existing Finnish strengths.
New funding of 4 M for 2011 is provided by the Ministry of Education and Culture through the Academy of Finland, with 1 M co-financing from the participating institutes; Institute for Molecular Medicine Finland (FIMM) at the University of Helsinki, CSC - IT Center for Science Ltd (CSC) and the National Institute for Health and Welfare (THL).
Specifically Biomedinfra will focus on three related pillars:
1) Improved biobanking infrastructures for epidemiological, biomedical and clinical research
2) High-performance computing infrastructure for facilitating next-generation biomedical data analysis needs
3) Translational infrastructure focusing on the application of biobanks to advance diagnostics and personalised medicine
Taken together, it is hoped that these infrastructures will eventually improve health care in Finland and in the EU. These infrastructures will be opened to international collaborations and provide research services. They will also help to integrate national Finnish research infrastructures with the European efforts.
Professor Olli Kallioniemi, Director of FIMM and coordinator of Biomedinfra, says "We are delighted about the opportunity to start building biomedical infrastructures that help Finland to co
|Contact: Olli Kallioniemi|
University of Helsinki